International data corp., Television channel

The Chinese Sinovac vaccine has been found to be far less effective than vaccines developed by Pfizer-BioNTech and Moderna, according to a Brazil government statement on Tuesday, which raised questions about the lack of transparency of Chinese-made vaccines.The efficacy of the Chinese-made vaccine was 50.38 per cent in Brazil's late-stage trials.While the number exceeds the threshold required for regulatory approval, it falls far below the 78 per cent previously announced, raising questions as to the veracity of the data and fueling skepticism over the apparent lack of transparency regarding Chinese vaccines, CNN reported.The Butantan Institute, which has been conducting the trials in Brazil, announced that the vaccine had a 78 per cent efficacy against mild to serve COVID-19 cases."The Butantan Institute and the Government of Sao Paulo reported that the coronavirus vaccine achieved a 50.38 per cent overall efficacy rate in the clinical study conducted in Brazil, in addition to (an efficacy rate of) 78 per cent for mild cases and 100 per cent for moderate and severe cases of Covid-19. All rates are higher than the 50 per cent level required by the WHO (World Health Orgzation)," according to a statement published by the government of Sao Paulo.The Sinovac vaccine is also less effective than its domestic Chinese competitor, developed by the state-owned Sinopharm, which it says is 79.34 per cent effective, CNN reported."Regarding the overall efficacy of the analysis, we met the requirements of the WHO with 50.38 per cent," CNN quoted Ricardo Palacios, medical director for clinical research at the Butantan biomedical center in Sao Paulo as saying.Yanzhong Huang, a senior fellow for global health at the US-based Council on Foreign Relations, described the 50.38 per cent efficacy of the Sinovac vaccine as a "disappointing" result.Russia's Sputnik V vaccine is 91 per cent effective, while the United Kingdom's vaccine, developed by Oxford University and AstraZeneca, has an average efficacy of 70 per cent.According to CNN, the Chinese Sinovac vaccine has signed deals to provide 46 million doses of its Covid-19 vaccine to Brazil.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

International Data Corp.FOLLOW

International data corp., Latest News

UK Prime Minister Boris Johnson on Friday (local time) announced that the country is temporarily closing all travel corridors from 4 am local time on Monday, a move that aims to prevent the spread of new variants of coronavirus into the country. ...

Following a surge in COVID-19 cases and the discovery of a new strain in the United Kingdom, French Prime Minister Jean Castex on Thursday announced that people travelling to and fro France will need to present a negative PCR test before arrival and ...

Dodger Stadium the largest site in Los Angeles, will launch as a mass vaccination site from Friday (local time), said the city's Mayor Eric Garcetti. ...

Chinese technology firm Huawei has backtracked on a patent application it filed for a facial recognition system meant to identify Uyghurs in China. According to a report by CNN, Huawei had filed a patent application saying "identification of pedestri ...

Two World Health Organisation (WHO) scientists en-route to China to investigate the origins of the pandemic are stuck in Singapore after testing positive for COVID-19 antibodies, the UN agency said on Thursday. ...

As President Donald Trump created history by becoming the only US president to be impeached twice, a source on Wednesday (local time) said the outgoing President is now in self-pity mode. ...

Former FBI Director James Comey on Wednesday said that the evidence he has seen so far suggests the attack on the US Capitol was a 'planned assault'. ...

The Chinese Sinovac vaccine has been found to be far less effective than vaccines developed by Pfizer-BioNTech and Moderna, according to a Brazil government statement on Tuesday, which raised questions about the lack of transparency of Chinese-made v ...